Published By : 16 May 2016 | Published By : QYRESEARCH
The global compression therapy market has been witnessing a steady rise in its valuation. The rapid increase in sports injuries has fueled the demand for this therapy significantly. The rising number of orthopedic surgeries and the escalating base of obese population is also boosting the worldwide market for compression therapy.
Demand for Advanced Therapy Propels North America Compression Therapy Market
North America led the global compression therapy market in 2015. The rising incidence of vascular diseases such as lymphedema, venous ulcers, and deep vein thrombosis has driven this market in North America over the last few years. Apart from this, the growing demand for advanced compression therapy products is also propelling the North America compression therapy market significantly.
The Europe market for compression therapy, which acquired the second position in 2015, is also expected to report a healthy in the coming years. The rising number of surgeries for the treatment of chronic diseases and orthopedic disorders, propelled by increasing geriatric population, is likely to stimulate this regional market in the near future.
Asia Pacific to Record Fastest Growth in Global Compression Therapy Market
The Asia Pacific market for compression therapy is projected to record the fastest growth among all the regional markets in the coming years. The rapid rise in the geriatric population in countries such as China, Japan, and Singapore is the key factor that is expected to fuel the demand for compression therapy, driving the regional market in near future.
The infrastructural development and the increasing disposable income in India, Malaysia, and China are also projected to add significantly to the market’s growth in the forthcoming years.
Bio Compression Systems Inc., Paul Hartmann AG, Covidien plc, Sigvaris, medi GmbH & Co. KG, BSN Medical, 3M Health Care, and ArjoHuntleigh are the major participants in the global compression therapy market.